Recently, the General Office of the Chengdu Municipal Government issued the "Several Policy Measures to Promote the High-Quality Development of the Biopharmaceutical Industry in Chengdu," proposing 25 policy measures from five aspects: supporting drug and medical device research and innovation, improving the quality and efficiency of clinical research, supporting the clinical application of products, supporting the development and growth of enterprises, and building a complete industrial ecosystem to promote industrial development. For the third-class medical devices that obtain a medical device registration certificate for the first time and have independent intellectual property rights, the "Policy" states that a reward of up to 5 million yuan will be given based on 20% of R&D investment. For those included in the national special approval or priority approval procedures for innovative medical devices, the maximum reward amount will be increased by another 1 million yuan, with a maximum annual reward of 10 million yuan for a single enterprise